{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T16:02:33Z","timestamp":1780761753872,"version":"3.54.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,4,5]],"date-time":"2026-04-05T00:00:00Z","timestamp":1775347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,5]],"date-time":"2026-04-05T00:00:00Z","timestamp":1775347200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["Ricerca corrente"],"award-info":[{"award-number":["Ricerca corrente"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012352","name":"Universit\u00e0 degli Studi di Milano","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100012352","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Backgroud<\/jats:title>\n                    <jats:p>Accurate localization of nonpalpable breast lesions in breast-conserving surgery (BCS) is essential for achieving oncological radicality, preserving cosmetic outcomes, and reducing reinterventions for positive margins. Radioguided occult lesion localization (ROLL) and magnetic seed localization (MSL) are established alternatives to wire-guided methods, but comparative evidence remains limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This prospective, single-centre, randomized clinical trial evaluated the noninferiority of MSL compared with ROLL in achieving negative surgical margins, assessed surgical, organizational, and patient-reported outcomes, and included a costs analysis. A total of 260 women with nonpalpable breast lesions suitable for BCS were enrolled between June 2023 and July 2025 and randomized 1:1 to ROLL or MSL. The primary endpoint was margin negativity. Secondary endpoints included calculated resection ratio (CRR), operative time, complications, hospital stay, reoperation rate, and EQ-5D-5L patient-reported outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Negative margins were achieved in 97.7% of ROLL and 93.1% of MSL cases (\n                      <jats:italic>p<\/jats:italic>\n                      = 0.14), confirming MSL noninferiority. Median CRR was identical (1.7,\n                      <jats:italic>p<\/jats:italic>\n                      = 0.61). Overall complication rates were comparable (6.2%-MSL vs. 4.7%-ROLL,\n                      <jats:italic>p<\/jats:italic>\n                      = 0.59), although postlocalization hematoma was more frequent with MSL (17% vs. 7%,\n                      <jats:italic>p<\/jats:italic>\n                      = 0.01). Hospital stay was significantly shorter with MSL (1 vs. 2 days,\n                      <jats:italic>p<\/jats:italic>\n                      = 0.001). Operative times were similar, and surgeon experience did not influence margin status, although attendings achieved lower CRR with ROLL. EQ-5D-5L scores were comparable except for \u201cusual activities\u201d dimension, which favoured ROLL.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>MSL was noninferior to ROLL, with comparable safety and patient-reported outcomes. Magnetic seed localization was found to be costs-saving across all analysed subgroups. Our results show that MSL is an effective alternative for lesion localization in BCS.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1245\/s10434-026-19587-0","type":"journal-article","created":{"date-parts":[[2026,4,5]],"date-time":"2026-04-05T16:46:04Z","timestamp":1775407564000},"page":"6403-6413","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A Prospective Randomized Trial Comparing Radioguided Occult Lesion Localization (ROLL) and Magnetic Seed Localization for the Localization of Nonpalpable Breast Lesions: Analysis of Surgical Outcomes, Patient\u2019s Perception, and Costs"],"prefix":"10.1245","volume":"33","author":[{"given":"Fabio","family":"Corsi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matilde","family":"Pelizzola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Bossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Zanella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvana","family":"Quaglini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Sottotetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Albasini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Morasso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,5]]},"reference":[{"key":"19587_CR1","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.breast.2022.02.004","volume":"62","author":"MG Davey","year":"2022","unstructured":"Davey MG, O\u2019Donnell JPM, Boland MR, et al. Optimal localization strategies for non-palpable breast cancers\u2014a network meta-analysis of randomized controlled trials. Breast. 2022;62:103\u201313. https:\/\/doi.org\/10.1016\/j.breast.2022.02.004.","journal-title":"Breast"},{"key":"19587_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2025.09.007","author":"HJ Burstein","year":"2025","unstructured":"Burstein HJ, Curigliano G, Gnant M, et al. Tailoring treatment to cancer risk and patient preference: the 2025 St Gallen International Breast Cancer Consensus Statement on individualizing therapy for patients with early breast cancer. Ann Oncol. 2025. https:\/\/doi.org\/10.1016\/j.annonc.2025.09.007.","journal-title":"Ann Oncol"},{"key":"19587_CR3","doi-asserted-by":"publisher","first-page":"12","DOI":"10.21037\/tbcr-23-49","volume":"5","author":"BHH Cheung","year":"2024","unstructured":"Cheung BHH, Co M, Lui TTN, Kwong A. Evolution of localization methods for non-palpable breast lesions: a literature review from a translational medicine perspective. Transl Breast Cancer Res. 2024;5:12. https:\/\/doi.org\/10.21037\/tbcr-23-49.","journal-title":"Transl Breast Cancer Res"},{"issue":"10","key":"19587_CR4","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1001\/jamaoncol.2017.0774","volume":"3","author":"M Morrow","year":"2017","unstructured":"Morrow M, Abrahamse P, Hofer TP, et al. Trends in reoperation after initial lumpectomy for breast cancer: addressing overtreatment in surgical management. JAMA Oncol. 2017;3(10):1352. https:\/\/doi.org\/10.1001\/jamaoncol.2017.0774.","journal-title":"JAMA Oncol"},{"issue":"5","key":"19587_CR5","first-page":"2423","volume":"36","author":"S Tardioli","year":"2016","unstructured":"Tardioli S, Ballesio L, Gigli S, et al. Wire-guided localization in non-palpable breast cancer: results from monocentric experience. Anticancer Res. 2016;36(5):2423\u20137.","journal-title":"Anticancer Res"},{"key":"19587_CR6","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009206.pub2","author":"BK Chan","year":"2015","unstructured":"Chan BK, Wiseberg-Firtell JA, Jois RH, Jensen K, Audisio RA. Localization techniques for guided surgical excision of non-palpable breast lesions. Cochrane Breast Cancer Group, ed. Cochrane Database Syst Rev. 2015. https:\/\/doi.org\/10.1002\/14651858.CD009206.pub2.","journal-title":"Cochrane Database Syst Rev"},{"key":"19587_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.breast.2025.104430","volume":"81","author":"Q Lin","year":"2025","unstructured":"Lin Q, Hou Q, Zhang C, et al. Innovations in the localization techniques for non-palpable breast lesions: make invisible visible. Breast. 2025;81:104430. https:\/\/doi.org\/10.1016\/j.breast.2025.104430.","journal-title":"Breast"},{"issue":"2","key":"19587_CR8","doi-asserted-by":"publisher","first-page":"znae007","DOI":"10.1093\/bjs\/znae007","volume":"111","author":"J Harvey","year":"2024","unstructured":"Harvey J, Morgan J, Lowes S, et al. Wire- and radiofrequency identification tag-guided localization of impalpable breast lesions: iBRA-NET localization study. British Journal of Surgery. 2024;111(2):znae007. https:\/\/doi.org\/10.1093\/bjs\/znae007.","journal-title":"British Journal of Surgery"},{"issue":"15","key":"19587_CR9","doi-asserted-by":"publisher","first-page":"5076","DOI":"10.3390\/jcm12155076","volume":"12","author":"S Parisi","year":"2023","unstructured":"Parisi S, Gambardella C, Conzo G, et al. Advanced localization technique for non-palpable breast cancer: radiofrequency alone vs. combined technique with ultrasound. JCM. 2023;12(15):5076. https:\/\/doi.org\/10.3390\/jcm12155076.","journal-title":"JCM"},{"issue":"9","key":"19587_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2024.108471","volume":"50","author":"G Giuliani","year":"2024","unstructured":"Giuliani G, Vitale R, Brunetti N, et al. Non-palpable breast lesions localization techniques\u2014a new priority: results of a Senonetwork survey among breast centers in Italy. Eur J Surg Oncol. 2024;50(9):108471. https:\/\/doi.org\/10.1016\/j.ejso.2024.108471.","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"19587_CR11","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1007\/s12282-020-01149-1","volume":"28","author":"AE Micha","year":"2021","unstructured":"Micha AE, Sinnett V, Downey K, et al. Patient and clinician satisfaction and clinical outcomes of Magseed compared with wire-guided localisation for impalpable breast lesions. Breast Cancer. 2021;28(1):196\u2013205. https:\/\/doi.org\/10.1007\/s12282-020-01149-1.","journal-title":"Breast Cancer"},{"issue":"3","key":"19587_CR12","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1111\/ans.70009","volume":"95","author":"M Bowles","year":"2025","unstructured":"Bowles M, Naing SS, Ng GS, Dauway E. Impact of Magseed\u00ae localization on re-excision rates of non-palpable breast cancers in an Australian regional hospital. ANZ J Surg. 2025;95(3):512\u20136. https:\/\/doi.org\/10.1111\/ans.70009.","journal-title":"ANZ J Surg"},{"issue":"1","key":"19587_CR13","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1186\/s12957-023-03152-0","volume":"21","author":"YH Elzohery","year":"2023","unstructured":"Elzohery YH, Gomaa MM, Mohamed G, Fadlalla WM, Taha SN, Ibraheem MH. Comparison of wire-guided localization (WGL) and radio-guided occult lesion localization (ROLL) in localization of non-palpable breast lesions. World J Surg Onc. 2023;21(1):266. https:\/\/doi.org\/10.1186\/s12957-023-03152-0.","journal-title":"World J Surg Onc"},{"issue":"2","key":"19587_CR14","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1002\/jso.20880","volume":"97","author":"H Medina-Franco","year":"2008","unstructured":"Medina-Franco H, Abarca-P\u00e9rez L, Garc\u00eda-Alvarez MN, Ulloa-G\u00f3mez JL, Romero-Trejo C, Sep\u00falveda-M\u00e9ndez J. Radioguided occult lesion localization (ROLL) versus wire-guided lumpectomy for non-palpable breast lesions: A randomized prospective evaluation. J Surg Oncol. 2008;97(2):108\u201311. https:\/\/doi.org\/10.1002\/jso.20880.","journal-title":"J Surg Oncol"},{"issue":"12","key":"19587_CR15","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1093\/annonc\/mdf343","volume":"13","author":"G Paganelli","year":"2002","unstructured":"Paganelli G, Luini A, Veronesi U. Radioguided occult lesion localization (ROLL) in breast cancer: maximizing efficacy, minimizing mutilation. Ann Oncol. 2002;13(12):1839\u201340. https:\/\/doi.org\/10.1093\/annonc\/mdf343.","journal-title":"Ann Oncol"},{"issue":"8","key":"19587_CR16","doi-asserted-by":"publisher","first-page":"e491","DOI":"10.1016\/j.clbc.2023.08.004","volume":"23","author":"C Depretto","year":"2023","unstructured":"Depretto C, Della Pepa G, De Berardinis C, et al. Magnetic localization of breast lesions: a large-scale European evaluation in a National Cancer Institute. Clinical Breast Cancer. 2023;23(8):e491\u20138. https:\/\/doi.org\/10.1016\/j.clbc.2023.08.004.","journal-title":"Clinical Breast Cancer"},{"issue":"3","key":"19587_CR17","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1001\/jamasurg.2023.6520","volume":"159","author":"E Pantiora","year":"2024","unstructured":"Pantiora E, Jazrawi A, Hersi AF, et al. Magnetic seed vs guidewire breast cancer localization with magnetic lymph node detection: a randomized clinical trial. JAMA Surg. 2024;159(3):239. https:\/\/doi.org\/10.1001\/jamasurg.2023.6520.","journal-title":"JAMA Surg"},{"issue":"14","key":"19587_CR18","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1200\/JCO.2013.53.3935","volume":"32","author":"MS Moran","year":"2014","unstructured":"Moran MS, Schnitt SJ, Giuliano AE, et al. Society of Surgical Oncology-American Society for Radiation Oncology Consensus Guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer. J Clin Oncol. 2014;32(14):1507\u201315. https:\/\/doi.org\/10.1200\/JCO.2013.53.3935.","journal-title":"J Clin Oncol"},{"issue":"2","key":"19587_CR19","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.ejso.2010.12.006","volume":"37","author":"NMA Krekel","year":"2011","unstructured":"Krekel NMA, Zonderhuis BM, Stockmann HBAC, et al. A comparison of three methods for nonpalpable breast cancer excision. Eur J Surg Oncol (EJSO). 2011;37(2):109\u201315. https:\/\/doi.org\/10.1016\/j.ejso.2010.12.006.","journal-title":"Eur J Surg Oncol (EJSO)"},{"issue":"10","key":"19587_CR20","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1007\/s11136-011-9903-x","volume":"20","author":"M Herdman","year":"2011","unstructured":"Herdman M, Gudex C, Lloyd A, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011;20(10):1727\u201336. https:\/\/doi.org\/10.1007\/s11136-011-9903-x.","journal-title":"Qual Life Res"},{"key":"19587_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2021.114519","volume":"292","author":"AP Finch","year":"2022","unstructured":"Finch AP, Meregaglia M, Ciani O, Roudijk B, Jommi C. An EQ-5D-5L value set for Italy using videoconferencing interviews and feasibility of a new mode of administration. Soc Sci Med. 2022;292:114519. https:\/\/doi.org\/10.1016\/j.socscimed.2021.114519.","journal-title":"Soc Sci Med"},{"issue":"6","key":"19587_CR22","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1007\/s10198-021-01411-z","volume":"23","author":"A Wang","year":"2022","unstructured":"Wang A, Rand K, Yang Z, Brooks R, Busschbach J. The remarkably frequent use of EQ-5D in non-economic research. Eur J Health Econ. 2022;23(6):1007\u201314. https:\/\/doi.org\/10.1007\/s10198-021-01411-z.","journal-title":"Eur J Health Econ"},{"key":"19587_CR23","doi-asserted-by":"crossref","unstructured":"Stolk E, Ramos-Go\u00f1i JM, Ludwig K, Oppe M, Norman R. The development and strengthening of methods for valuing EQ-5D-5L\u2014An overview. In: Devlin N, Roudijk B, Ludwig K (eds) Value sets for EQ-5D-5L: a compendium, comparative review & user guide. Springer; 2022. Accessed February 6, 2026. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK589298\/","DOI":"10.1007\/978-3-030-89289-0_2"},{"issue":"5","key":"19587_CR24","doi-asserted-by":"publisher","first-page":"zraf104","DOI":"10.1093\/bjsopen\/zraf104","volume":"9","author":"CL Nguyen","year":"2025","unstructured":"Nguyen CL, Kwok J, Zhou M, et al. Indocyanine green versus technetium-99 m for sentinel lymph node biopsy in breast cancer: the FLUORO trial. BJS Open. 2025;9(5):zraf104. https:\/\/doi.org\/10.1093\/bjsopen\/zraf104.","journal-title":"BJS Open"},{"issue":"4","key":"19587_CR25","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1002\/hpm.3431","volume":"37","author":"CD Christou","year":"2022","unstructured":"Christou CD, Athanasiadou EC, Tooulias AI, Tzamalis A, Tsoulfas G. The process of estimating the cost of surgery: providing a practical framework for surgeons. Health Plan Manag. 2022;37(4):1926\u201340. https:\/\/doi.org\/10.1002\/hpm.3431.","journal-title":"Health Plan Manag"},{"issue":"7","key":"19587_CR26","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1177\/0962280216677107","volume":"27","author":"W Zhao","year":"2018","unstructured":"Zhao W, Berger VW, Yu Z. The asymptotic maximal procedure for subject randomization in clinical trials. Stat Methods Med Res. 2018;27(7):2142\u201353. https:\/\/doi.org\/10.1177\/0962280216677107.","journal-title":"Stat Methods Med Res"},{"issue":"3","key":"19587_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2025.109579","volume":"51","author":"F Corsi","year":"2025","unstructured":"Corsi F, Cabri GF, Albasini S, Bossi D, Truffi M. Management of B3 breast lesions: Potential clinical implications from a retrospective study conducted in an accredited Breast Unit following the 2024 EUSOMA guidelines. Eur J Surg Oncol. 2025;51(3):109579. https:\/\/doi.org\/10.1016\/j.ejso.2025.109579.","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"19587_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2023.107292","volume":"50","author":"IT Rubio","year":"2024","unstructured":"Rubio IT, Wyld L, Marotti L, et al. European guidelines for the diagnosis, treatment and follow-up of breast lesions with uncertain malignant potential (B3 lesions) developed jointly by EUSOMA, EUSOBI, ESP (BWG) and ESSO. Eur J Surg Oncol. 2024;50(1):107292. https:\/\/doi.org\/10.1016\/j.ejso.2023.107292.","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"19587_CR29","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s00428-021-03182-7","volume":"480","author":"J Kulka","year":"2022","unstructured":"Kulka J, Madaras L, Floris G, Lax SF. Papillary lesions of the breast. Virchows Arch. 2022;480(1):65\u201384. https:\/\/doi.org\/10.1007\/s00428-021-03182-7.","journal-title":"Virchows Arch"},{"issue":"11","key":"19587_CR30","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.3390\/biomedicines12112466","volume":"12","author":"A Drozgyik","year":"2024","unstructured":"Drozgyik A, Koll\u00e1r D, Dankh\u00e1zi L, Harmati I\u00c1, Szalay K, Moln\u00e1r TF. Non-palpable breast cancer: a targeting challenge\u2014comparison of radio-guided vs wire-guided localization techniques. Biomedicines. 2024;12(11):2466. https:\/\/doi.org\/10.3390\/biomedicines12112466.","journal-title":"Biomedicines"},{"issue":"1","key":"19587_CR31","doi-asserted-by":"publisher","first-page":"9960666","DOI":"10.1155\/ijbc\/9960666","volume":"2025","author":"A Villanucci","year":"2025","unstructured":"Villanucci A, Ferranti FR, Cappelli S, et al. Preoperative magnetic seed versus wire-guided localization in the treatment of nonpalpable breast cancer: a retrospective observational study at a tertiary care center. Ahmad I, ed. Int J Breast Cancer. 2025;2025(1):9960666. https:\/\/doi.org\/10.1155\/ijbc\/9960666.","journal-title":"Int J Breast Cancer"},{"issue":"4","key":"19587_CR32","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.3390\/cancers15041173","volume":"15","author":"M Banys-Paluchowski","year":"2023","unstructured":"Banys-Paluchowski M, K\u00fchn T, Masannat Y, et al. Localization techniques for non-palpable breast lesions: current status, knowledge gaps, and rationale for the MELODY study (EUBREAST-4\/iBRA-NET, NCT 05559411). Cancers (Basel). 2023;15(4):1173. https:\/\/doi.org\/10.3390\/cancers15041173.","journal-title":"Cancers (Basel)"},{"issue":"7","key":"19587_CR33","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.3390\/medicina59071297","volume":"59","author":"S Shirazi","year":"2023","unstructured":"Shirazi S, Hajiesmaeili H, Khosla M, Taj S, Sircar T, Vidya R. Comparison of wire and non-wire localisation techniques in breast cancer surgery: a review of the literature with pooled analysis. Medicina (Kaunas). 2023;59(7):1297. https:\/\/doi.org\/10.3390\/medicina59071297.","journal-title":"Medicina (Kaunas)"},{"issue":"6","key":"19587_CR34","doi-asserted-by":"publisher","first-page":"3223","DOI":"10.1245\/s10434-020-09311-x","volume":"28","author":"ME Miller","year":"2021","unstructured":"Miller ME, Patil N, Li P, et al. Hospital system adoption of magnetic seeds for wireless breast and lymph node localization. Ann Surg Oncol. 2021;28(6):3223\u20139. https:\/\/doi.org\/10.1245\/s10434-020-09311-x.","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"19587_CR35","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/s10549-018-4709-y","volume":"169","author":"JR Harvey","year":"2018","unstructured":"Harvey JR, Lim Y, Murphy J, et al. Safety and feasibility of breast lesion localization using magnetic seeds (Magseed): a multi-centre, open-label cohort study. Breast Cancer Res Treat. 2018;169(3):531\u20136. https:\/\/doi.org\/10.1007\/s10549-018-4709-y.","journal-title":"Breast Cancer Res Treat"},{"key":"19587_CR36","unstructured":"Yeung SST, Farrah K. Magnetic Seed localization for soft tissue lesions in breast patients: clinical effectiveness, cost-effectiveness, and guidelines. Canadian Agency for Drugs and Technologies in Health; 2019. Accessed November 5, 2025. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK545815\/"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-19587-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-026-19587-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-19587-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T15:51:30Z","timestamp":1780761090000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-026-19587-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,5]]},"references-count":36,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["19587"],"URL":"https:\/\/doi.org\/10.1245\/s10434-026-19587-0","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,5]]},"assertion":[{"value":"15 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest that could have appeared to influence the work reported in this paper.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}},{"value":"Institute\u2019s ethical approval: CE 2778, ClinicalTrials.gov Identifier: NCT05942118.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}